Table 1.
Altered expression of Ca2+ handling proteins in critical illness myopathy
| Protein Measured | Control | CIM |
|---|---|---|
| RYR1 | 100 ± 2.5 | 135 ± 6.5** |
| RYR2 | 100 ± 4.3 | 171 ± 13** |
| CaV 1.1 | 100 ± 5.1 | 133 ± 9.5** |
| CaV 1.2 | 100 ± 5.0 | 60 ± 7.3** |
| ORAI, type 1 | 100 ± 2.5 | 77 ± 4.9** |
| NaV 1.4 | 100 ± 7.6 | 97 ± 5.2 |
| β-Tubulin | 100 ± 5.8 | 117 ± 6.9 |
Data are means ± SE; control, n = 19; CIM, n = 16. Values are %average control ± SE. RYR1, ryanodine receptor type 1; RYR2, RYR type 2; CaV 1.1; voltage-gated Ca2+ channel type 1.1; CaV 1.2, CaV type 1.2; ORAI type 1, Ca2+ release-activated Ca2+ protein 1; NaV 1.4, voltage-gated sodium channel type 1.4.
P < 0.01 for CIM relative to control.